TRIBUTA: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer
- Author
- HERBST, Roy S; PRAGER, Diane; RAMIES, David; JOHNSON, David H; MILLER, Vincent A; HERMANN, Robert; FEHRENBACHER, Lou; JOHNSON, Bruce E; SANDLER, Alan; KRIS, Mark G; TRAN, Hai T; KLEIN, Pam; XIN LI
[1] The University of Texas M D Anderson Cancer Center, Houston, TX, United States
[2] University of California Los Angeles, Los Angeles, United States
[3] Kaiser Permanente, Oakland, United States
[4] Genentech Inc, South San Francisco, CA, United States
[5] Georgia Oncology Partners, Marietta, GA, United States
[6] Dana-Farber Cancer Institute, Boston, MA, United States
[7] Vanderbilt-Ingram Cancer Center, Nashville, TN, United States
[8] Memorial Sloan-Kettering Cancer Center, New York, NY, United States - Source
Journal of clinical oncology. 2005, Vol 23, Num 25, pp 5892-5899, 8 p ; ref : 22 ref
- ISSN
- 0732-183X
- Scientific domain
- Medical oncology
- Publisher
- Lippincott Williams & Wilkins, Baltimore, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Cancer du poumon Cancérologie Carboplatine Carcinome non petite cellule bronchopulmonaire Chlorhydrate Erlotinib Essai clinique phase III Paclitaxel Stade avancé Traitement associé Inhibiteur tyrosine kinase Antimitotique Appareil respiratoire pathologie Bronche pathologie Enzyme Inhibiteur enzyme Platine II Complexe Poumon pathologie Protein-tyrosine kinase Quinazoline dérivé Récepteur facteur croissance épiderme Taxane dérivé Transferases Tumeur maligne
- Keyword (en)
- Antineoplastic agent Lung cancer Cancerology Carboplatin non-small cell lung carcinoma Hydrochlorides Erlotinib Phase III trial Paclitaxel Advanced stage Combined treatment Antimitotic Respiratory disease Bronchus disease Enzyme Enzyme inhibitor Platinum II Complexes Lung disease Protein-tyrosine kinase Quinazoline derivatives Epidermal growth factor receptor Taxane derivatives Transferases Malignant tumor
- Keyword (es)
- Anticanceroso Cáncer del pulmón Cancerología Carboplatino Carcinoma no pequeňa célula bronchopulmonar Hidrocloruro Erlotinib Ensayo clínico fase III Paclitaxel Estadio avanzado Tratamiento asociado Antimitótico Aparato respiratorio patología Bronquio patología Enzima Inhibidor enzima Platino II Complejo Pulmón patología Protein-tyrosine kinase Receptor factor crecimiento epidermi Taxane derivado Transferases Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11A Tumors of the respiratory system and mediastinum
- Discipline
- Pulmonology Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 17650582
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1200/JCO.2005.02.840 
https://dx.doi.org/10.1200/JCO.2005.02.840
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2005.02.840\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:156:\"TRIBUTA: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"25\";s:8:\"\u0000*\u0000spage\";s:4:\"5892\";s:8:\"\u0000*\u0000epage\";s:4:\"5899\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"HERBST\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Roy S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:13:\"PRAGER, Diane\";i:1;s:13:\"RAMIES, David\";i:2;s:16:\"JOHNSON, David H\";i:3;s:17:\"MILLER, Vincent A\";i:4;s:15:\"HERMANN, Robert\";i:5;s:17:\"FEHRENBACHER, Lou\";i:6;s:16:\"JOHNSON, Bruce E\";i:7;s:13:\"SANDLER, Alan\";i:8;s:12:\"KRIS, Mark G\";i:9;s:11:\"TRAN, Hai T\";i:10;s:10:\"KLEIN, Pam\";i:11;s:6:\"XIN LI\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:156:\"TRIBUTA: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2005.02.840\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:156:\"TRIBUTA: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"25\";s:8:\"\u0000*\u0000spage\";s:4:\"5892\";s:8:\"\u0000*\u0000epage\";s:4:\"5899\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"HERBST\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Roy S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:13:\"PRAGER, Diane\";i:1;s:13:\"RAMIES, David\";i:2;s:16:\"JOHNSON, David H\";i:3;s:17:\"MILLER, Vincent A\";i:4;s:15:\"HERMANN, Robert\";i:5;s:17:\"FEHRENBACHER, Lou\";i:6;s:16:\"JOHNSON, Bruce E\";i:7;s:13:\"SANDLER, Alan\";i:8;s:12:\"KRIS, Mark G\";i:9;s:11:\"TRAN, Hai T\";i:10;s:10:\"KLEIN, Pam\";i:11;s:6:\"XIN LI\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:156:\"TRIBUTA: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2005.02.840\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2005.02.840\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:156:\"TRIBUTA: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"25\";s:8:\"\u0000*\u0000spage\";s:4:\"5892\";s:8:\"\u0000*\u0000epage\";s:4:\"5899\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"HERBST\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Roy S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:13:\"PRAGER, Diane\";i:1;s:13:\"RAMIES, David\";i:2;s:16:\"JOHNSON, David H\";i:3;s:17:\"MILLER, Vincent A\";i:4;s:15:\"HERMANN, Robert\";i:5;s:17:\"FEHRENBACHER, Lou\";i:6;s:16:\"JOHNSON, Bruce E\";i:7;s:13:\"SANDLER, Alan\";i:8;s:12:\"KRIS, Mark G\";i:9;s:11:\"TRAN, Hai T\";i:10;s:10:\"KLEIN, Pam\";i:11;s:6:\"XIN LI\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:156:\"TRIBUTA: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2005.02.840\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:156:\"TRIBUTA: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"25\";s:8:\"\u0000*\u0000spage\";s:4:\"5892\";s:8:\"\u0000*\u0000epage\";s:4:\"5899\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"HERBST\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Roy S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:13:\"PRAGER, Diane\";i:1;s:13:\"RAMIES, David\";i:2;s:16:\"JOHNSON, David H\";i:3;s:17:\"MILLER, Vincent A\";i:4;s:15:\"HERMANN, Robert\";i:5;s:17:\"FEHRENBACHER, Lou\";i:6;s:16:\"JOHNSON, Bruce E\";i:7;s:13:\"SANDLER, Alan\";i:8;s:12:\"KRIS, Mark G\";i:9;s:11:\"TRAN, Hai T\";i:10;s:10:\"KLEIN, Pam\";i:11;s:6:\"XIN LI\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:156:\"TRIBUTA: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1200\/JCO.2005.02.840\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:156:\"TRIBUTA: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:2:\"25\";s:8:\"\u0000*\u0000spage\";s:4:\"5892\";s:8:\"\u0000*\u0000epage\";s:4:\"5899\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"HERBST\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Roy S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:13:\"PRAGER, Diane\";i:1;s:13:\"RAMIES, David\";i:2;s:16:\"JOHNSON, David H\";i:3;s:17:\"MILLER, Vincent A\";i:4;s:15:\"HERMANN, Robert\";i:5;s:17:\"FEHRENBACHER, Lou\";i:6;s:16:\"JOHNSON, Bruce E\";i:7;s:13:\"SANDLER, Alan\";i:8;s:12:\"KRIS, Mark G\";i:9;s:11:\"TRAN, Hai T\";i:10;s:10:\"KLEIN, Pam\";i:11;s:6:\"XIN LI\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:156:\"TRIBUTA: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer\";s:8:\"\u0000*\u0000place\";s:13:\"Baltimore, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
